Browse by Journal / Conference

Sankaradoss, A and Jagtap, S and Nazir, J and Moula, SE and Modak, A and Fialho, J and Iyer, M and Shastri, JS and Dias, M and Gadepalli, R and Aggarwal, A and Vedpathak, M and Agrawal, S and Pandit, A and Nisheetha, A and Kumar, A and Bordoloi, M and Shafi, M and Shelar, B and Balachandra, SS and Damodar, T and Masika, MM and Mwaura, P and Anzala, O and Muthumani, K and Sowdhamini, R and Medigeshi, GR and Roy, R and Pattabiraman, C and Krishna, S and Sreekumar, E (2022) Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences. In: Molecular Therapy .

Sen, Dwaipayan and Gadkari, Rupali A and Sudha, Govindarajan and Gabriel, Nishanth and Ramya, V and Nair, Sukesh C and Srinivasan, N and Srivastava, Alok and Jayandharan, Giridhara R (2013) A novel adeno-associated virus serotype (AAV)-8 capsid mutant improves human coagulation factor IX expression in vivo. In: Molecular Therapy, 21 (1). S47-S47.

Sen, Dwaipayan and Kalaivani, V and Gadkari, Rupali and Sudha, G and Srinivasan, N and Srivastava, Alok and Jayandharan, Giridhara R (2013) Multiple molecular alterations in phosphodegrons 1-3 within AAV2 capsid demonstrates higher hepatic gene transfer efficiency. In: Molecular Therapy, 21 (1). S206-S207.

Hareendran, Sangeetha and Hussain, Mansoor and Sen, Dwaipayan and Balakrishnan, Balaji and SathishKumar, Yesupatham and Kalaivani, Vaani and Ramakrishna, Banumathi and Srivastava, Arun and Srivastava, Alok and Jayandharan, Giridhara Rao (2012) Bio-Engineering of Adeno-Associated Virus Serotype (AAV)-2 Capsid at Serine/Threonine Residues Improves Its Transduction Efficiency Both In Vitro and In Vivo. In: Molecular Therapy, 20 (1).

Gabriel, Nishanth and Duraiswamy, Ramya and Gadkari, Rupali A and Govindarajan, Sudha and Ramakrishna, Banumathi and Srivastava, Arun and Srinivasan, N and Srivastava, Alok and Jayandharan, Giridhara Rao (2012) Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno-Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency. In: Molecular Therapy, 20 (1). p. 146.